Vimarsana
Biggest News Aggregation in the World

Page 5 - Third Dose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Third Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Third Dose Today - Breaking & Trending Today

COVID-19: 3 shots generate good response in under 5-yr-olds, says Pfizer - Vimarsana News

COVID-19: 3 shots generate good response in under 5-yr-olds, says Pfizer

The companies said the vaccine was safe and well-tolerated by the children, and they plan to soon ask global regulators to authorize the shot for the age group.

Vaccination for children aged 5-11 in Vietnam lagging behind: ministry - Vimarsana News

Vaccination for children aged 5-11 in Vietnam lagging behind: ministry

HANOI, May 18 (Xinhua) -- Vietnam Ministry of Health has called for speeding up COVID-19 vaccination for children aged five to 11 across the country, and accele

Gap between second and third Covid vaccine dose reduced to 90 days for those travelling abroad - Vimarsana News

Gap between second and third Covid vaccine dose reduced to 90 days for those travelling abroad

Covid vaccine, booster dose, second dose, third dose, booster dose gap, covid vaccination, vaccination, covid vaccination, covid vaccine dose

Coronavirus: is a sixth wave of infections about to hit Hong Kong and should social-distancing curbs be tightened? - Vimarsana News

Coronavirus: is a sixth wave of infections about to hit Hong Kong and should social-distancing curbs be tightened?

Caseloads to fluctuate for longer period of time with relaxation of social-distancing curbs, says microbiologist Dr Ho Pak-leung.

Source: scmp.com
Efficacy and safety of a 3rd dose of mRNA-1273 SARS-CoV-2 vaccine - Vimarsana News

Efficacy and safety of a 3rd dose of mRNA-1273 SARS-CoV-2 vaccine

In a recent study posted to the Research Square* preprint server, researchers tested the safety and immunogenicity of a third dose of coronavirus disease 2019 (COVID-19) prototype messenger ribonucleic acid (mRNA)-1273 versus a variant vaccine and a bivalent vaccine formulation.